FOR IMMEDIATE RELEASE MAY 9, 2018
Contact: Tara Downes
COMPTROLLER LEMBO COMMENDS SENATE FOR UNANIMOUS VOTE THAT SENDS GROUNDBREAKING PRESCRIPTION DRUG BILL TO GOVERNOR
Comptroller Kevin Lembo today praised the state Senate for unanimously approving legislation that will establish new groundbreaking transparency requirements for pharmaceutical corporations when drug prices skyrocket.
House Bill 5384, An Act Concerning Prescription Drug Costs, was championed through the House last week by State Rep. Sean Scanlon (D-Guilford), co-chair of the Insurance and Real Estate Committee. The legislation now heads to the governor for signature.
"This is an extraordinary victory for Connecticut patients who pay outrageous prices at the counter while powerful corporations are enriched by big discounts," Lembo said. "The extreme wealth exchange between corporate giants, from pharmaceutical manufacturers to pharmacy benefit managers to insurance companies, will no longer happen in the dark. This legislative victory is a groundbreaking step, but the fight for fairness has only just begun as we continue the fight for relief at the pharmacy counter."
"I am grateful to legislative leadership, and particularly Rep. Scanlon, for their commitment to pharmaceutical market reform – and urge the governor for his support."